February 27, 2017 by Greg Jacobson and Chain Drug Review
ACA, ACA exchanges, Aetna, Affordable Care Act, Health and Human Services, health insurance exchanges, Humana, Mark Bertolini, Obamacare, Tom Price, Trump administration
2017, Issue 02-27-2017, Issues, News

WASHINGTON — Humana Inc.’s decision to pull out of the health insurance exchanges created by the Affordable Care Act threatens to cripple Obamacare before Republican lawmakers bent on its repeal can cobble together a replacement. The Humana decision came one day before the Trump administration issued a proposed rule that attempts to offer insurers more
February 21, 2017 by Greg Jacobson and Chain Drug Review
ACA, Aetna, Affordable Care Act, health insurance exchanges, Humana, Mark Bertolini, Obamacare, Tom Price
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Humana Inc.’s decision to pull out of the health insurance exchanges created by the Affordable Care Act threatens to cripple Obamacare before Republican lawmakers bent on its repeal can cobble together a replacement. The Humana decision came one day before the Trump White House issued a proposed rule that attempts to offer insurers
September 26, 2016 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, Avalere, Dan Mendelson, Drew Altman, health insurance, health insurance exchanges, HealthCare.gov, Kaiser Family Foundation
2016, Issue 09-26-2016, Issues, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — The upcoming enrollment period for the Affordable Care Act will be pivotal, as hikes in premiums, withdrawals by insurance companies and sign-ups that fell short of targets have combined to call the law’s sustainability into question. Federal officials say the problems is surmountable and are driving to bolster the statute before President Obama
September 6, 2016 by Geoff Walden and Chain Drug Review
ACA enrollment, Aetna, Affordable Care Act, Drew Altman, health insurance exchanges, health insurance marketplaces, Humana, Kaiser Family Foundation, Marilyn Tavenner, Mark Bertolini, UnitedHealth Group
Issue 09-12-2016, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — The pullback of health insurance companies from the Affordable Care Act has focused a harsh light on President Obama’s signature legislative achievement. Most recently, Aetna Inc. decided to drop out of ACA health insurance exchanges in 11 states with about two-thirds of the 778 counties where it now offers coverage. It will continue
June 6, 2016 by John Schultz and Chain Drug Review
ACA, Affordable Care Act, Avalere Health, health insurance exchanges, HealthCare.gov, Humana, Kevin Counihan
2016, Issue 06-06-2016, Issues, News
WASHINGTON — Large health plans that have claimed financial challenges from their participation in health insurance exchanges under the Affordable Care Act are set to seek significant premium increases in about a dozen states where they operate those individual plans. Others are limiting the number of plans offered if not vacating states altogether. Plans in
February 22, 2016 by John Schultz and Chain Drug Review
Affordable Care Act, Andy Slavitt, Centers for Medicaid and Medicare Services, Health and Human Services, health insurance exchanges, HealthCare.gov, Sylvia Burwell
2016, Issue 02-22-2016, Issues, News
WASHINGTON — About 12.7 million Americans signed up for 2016 health insurance coverage through the government insurance exchanges, surpassing expectations, Health and Human Services Secretary Sylvia Burwell said earlier this month. The government began offering subsidies for individual insurance in 2014 under the Affordable Care Act, frequently referred to as Obamacare, and charges a penalty
December 7, 2015 by Geoff Walden and Chain Drug Review
Affordable Care Act, health insurance exchanges, Health Insurance Marketplace, HealthCare.gov, UnitedHealth Group
2015, Issue 12-07-2015, Issues, Leading Headlines, News, Pharmacy, Retail News

NEW YORK — UnitedHealth Group Inc. may pull out of Affordable Care Act health insurance exchanges in 2017 after losing what it said were hundreds of millions of dollars on policies sold under the law. The company, the nation’s largest health insurer, significantly cut its 2015 profit estimates based on losses on individual policies sold
October 26, 2015 by Geoff Walden and Chain Drug Review
Affordable Care Act, health insurance, health insurance exchanges, Medicaid, open enrollment, Sylvia Burwell
2015, Issue 10-26-2015, Issues, News, Pharmacy

WASHINGTON — Slow growth is foreseen for health insurance enrollment through the Affordable Care Act exchanges, the Obama administration said this month. Coverage by the end of 2016 will barely exceed current levels, the administration said. Sign-ups during the ACA’s upcoming open enrollment season will bring the number of covered individuals to 10 million, up
October 12, 2015 by John Schultz and Chain Drug Review
Affordable Care Act, Department of Health and Human Services, health insurance, health insurance exchanges, open enrollment, Sylvia Burwell
2015, Issue 10-12-2015, Issues, News, Retail News

WASHINGTON — The government vows to conduct an extensive outreach initiative during the Affordable Care Act’s upcoming open enrollment period in an attempt to enroll millions of eligible but difficult-to-reach Americans who have yet to sign up for health insurance. “Those who are still uninsured are going to be a bigger challenge,” Department of Health
July 6, 2015 by Mark Baumgartner and Chain Drug Review
Affordable Care Act, health insurance, health insurance exchanges, King v. Burwell, National Association of Chain Drug Stores, National Community Pharmacists Association, National Retail Federation, Supreme Court
Issue 07-06-2015, Issues, News
WASHINGTON — The Affordable Care Act has survived its second Supreme Court challenge, with a divided court agreeing with the Obama administration that government subsidies that make health insurance affordable for millions of poor and middle-class Americans should be available nationwide. While there are more challenges to come, the organization representing the nation’s traditional drug
March 16, 2015 by Geoff Walden and Chain Drug Review
Affordable Care Act, health insurance, health insurance exchanges, health insurance subsidies, King v. Burwell, Supreme Court, Sylvia Burwell
2015, Issue 03-16-2015, News

WASHINGTON — The fate of the Affordable Care Act rests with the Supreme Court. The court this month heard arguments in a case that the Obama administration says could gut the law. It will decide whether some 7 million low- and middle-income people in about three-dozen states will continue to receive subsidies under the law